TrialThe oncologist2019

A Phase II Study of S-1 and Paclitaxel Combination Therapy as a First-Line Treatment in Elderly Patients with Advanced Non-Small Cell Lung Cancer.

Akihiro Yoshimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.